Is it Too Late to Buy UnitedHealth Stock?
UnitedHealth Group (UNH) has posted a 60% jump in earnings while raising full-year guidance for the third time this year, a sequence that signals management is fixing the miscalculations that dented its 2025 results.
The raised outlook is the key data point. Three guidance increases in a single year show repeated upside versus the company's own internal forecasts, and the 60% earnings gain gives that revision real weight behind it. Management's execution is now the core of the bull argument around UNH, according to The Motley Fool's analysis, which frames the central question as whether the stock's recent strong performance has already priced in the recovery.
Interpretation: a stock that has rallied on a turnaround story faces a different risk profile than one still depressed by operational errors. The easy rebound from correcting 2025 missteps may be largely captured, leaving future gains dependent on whether UNH can keep clearing its own raised targets. A fourth guidance raise would extend the pattern; a pause would test whether expectations have run ahead of results.